Strategic science communication as planned behavior: Understanding scientists’ willingness to choose specific tactics

Strategic science communicators need to select tactics that can help them achieve both their short-term communication objectives and long-term behavioral goals. However, little previous research has sought to develop theory aimed at understanding what makes it more likely that a communicator will prioritize specific communication tactics. The current study aims to advance the development of a theory of strategic science communication as planned behavior based on the Integrated Behavioral Model. It does so in the context of exploring Canadian scientists’ self-reported willingness to prioritize six different tactics as a function of attitudinal, normative, and efficacy beliefs. The results suggest that scientists’ beliefs about ethicality, norms, response efficacy, and self-efficacy, are all meaningful predictors of willingness to prioritize specific tactics. Differences between scientists in terms of demographics and related variables provide only limited benefit in predicting such willingness

Morphology controls the thermoelectric power factor of a doped semiconducting polymer.

The electrical performance of doped semiconducting polymers is strongly governed by processing methods and underlying thin-film microstructure. We report on the influence of different doping methods (solution versus vapor) on the thermoelectric power factor (PF) of PBTTT molecularly p-doped with F n TCNQ (n = 2 or 4). The vapor-doped films have more than two orders of magnitude higher electronic conductivity (σ) relative to solution-doped films. On the basis of resonant soft x-ray scattering, vapor-doped samples are shown to have a large orientational correlation length (OCL) (that is, length scale of aligned backbones) that correlates to a high apparent charge carrier mobility (μ). The Seebeck coefficient (α) is largely independent of OCL. This reveals that, unlike σ, leveraging strategies to improve μ have a smaller impact on α. Our best-performing sample with the largest OCL, vapor-doped PBTTT:F4TCNQ thin film, has a σ of 670 S/cm and an α of 42 μV/K, which translates to a large PF of 120 μW m-1 K-2. In addition, despite the unfavorable offset for charge transfer, doping by F2TCNQ also leads to a large PF of 70 μW m-1 K-2, which reveals the potential utility of weak molecular dopants. Overall, our work introduces important general processing guidelines for the continued development of doped semiconducting polymers for thermoelectrics

Anthropometrics

This document summarizes the rationale, equipment, measurement, protocol and data cleaning procedures for each of the anthropometric measures collected at Wave V. It also documents how constructed variables were derived from the anthropometric measures collected in the field. Whenever possible, data collection and methods in Wave V mirrored those of Wave IV to ensure comparability of data between waves. This document is one in a set of Wave V user guides

Medication Use - Biomarker Home Exam

This document summarizes the rationale, equipment, measurement, and protocol procedures for the medication inventories collected during Wave V. It also documents the protocol for assigning therapeutic classes to those medications. Whenever possible, data collection and methods in Wave V mirrored those of Wave IV to ensure comparability of data between waves. This document is one in a set of Wave V user guides

Measures of Inflammation and Immune Function

This document summarizes the rationale, equipment, protocol assays, internal quality control, data cleaning, external quality control, and procedures for the measurement and classification of inflammation at the Wave V home exam. Whenever possible, data collection and methods in Wave V mirrored those of Wave IV to ensure comparability of data between waves, although important inter-Wave differences exist and are grey-highlighted herein. This document is one in a set of Wave V user guides

Renal Function

This document summarizes the rationale, equipment, protocol, assay, internal quality control, data cleaning, external quality control, and procedures for the measurement and classification of kidney (renal) function at the Wave V home exam. Whenever possible, data collection and methods in Wave V mirrored those of Wave IV to ensure comparability of data between waves, although important inter-Wave differences exist and are grey highlighted herein. This document is one in a set of Wave V user guides

Measures of Inflammation and Immune Function

This document summarizes the rationale, equipment, protocol assays, internal quality control, data cleaning, external quality control, and procedures for the measurement and classification of inflammation at the Wave V home exam. Whenever possible, data collection and methods in Wave V mirrored those of Wave IV to ensure comparability of data between waves, although important inter-Wave differences exist and are grey-highlighted herein. This document is one in a set of Wave V user guides. User guides are also available to describe protocols for the following biological measures in Wave V: Anthropometrics, Cardiovascular Measures, Medication Use – Home Exam, Baroreflex Sensitivity & Hemodynamic Recovery, Glucose Homeostasis, Lipids, Renal Function Additional assays were subsequently performed using archived blood samples from Wave V to mirror those measures that will be analyzed in Add Health Wave VI. None of these additional assays were performed during Wave IV. Those user guides include: Hepatic Injury, Neurodegeneratio

Measures of Glucose Homeostasis

This document summarizes the rationale, equipment, protocol, assays, internal quality control, data cleaning, external quality control, and procedures for the measurement and classification of glucose homeostasis at the Wave V home exam. Whenever possible, data collection and methods in Wave V mirrored those of Wave IV to ensure comparability of data between waves, although important inter-Wave differences exist and are grey-highlighted herein. This document is one in a set of Wave V user guides

Add Health Wave V Documentation: Cardiovascular Measures

This document summarizes the rationale, equipment, measurement, protocol and data cleaning procedures for each of the cardiovascular measures collected at the Wave V home exam. It also documents how constructed variables were derived from the cardiovascular measures collected in the field. Whenever possible, data collection and methods in Wave V mirrored those of Wave IV to ensure comparability of data between waves. This document is one in a set of Wave V user guides. User guides are also available to describe protocols for the following biological measures in Wave V: ▪ Anthropometrics ▪ Medication Use ▪ Baroreflex Sensitivity & Hemodynamic Recovery ▪ Glucose Homeostasis ▪ Inflammation and Immune Function ▪ Lipids ▪ Renal Function ▪ Liver Enzyme

Neurodegeneration

Wave V measures of neurodegeneration were based on venous blood collected via phlebotomy. The blood was collected by field examiners (FEs) certified in phlebotomy, chilled at 4°C during the remainder of the home exam, centrifuged immediately afterward, aliquoted into transport tubes, sent overnight to a laboratory, archived at -80°C, subsequently thawed at 36°C, and then assayed. Assayed Neurodegeneration Biomarker Concentrations • Neurofilament Light (NfL, pg/ml) • Tau (pg/ml) Moreover, the restricted use Add Health Wave V data include two constructed measures designed to facilitate analysis and interpretation of neurodegeneration biomarker concentrations: • Flag Indicating the NfL Concentration Type • Flag Indicating the Tau Concentration Typ